(Press-News.org) New Rochelle, NY, Mar 19, 2013—Chronic fatigue, a persistent lack of energy that does not improve with rest, is at least three times more prevalent among adult survivors of acute lymphoblastic leukemia and lymphoma experienced during childhood or adolescence than in the general adult population, according to an article in Journal of Adolescent and Young Adult Oncology (JAYAO), (http://www.liebertpub.com/JAYAO) a multidisciplinary peer-reviewed publication from Mary Ann Liebert, Inc., publishers. (http://www.liebertpub.com) JAYAO is the Official Journal of the Society for Adolescent and Young Adult Oncology (http://www.sayao.org). The article is available online on the JAYAO (http://www.liebertpub.com/JAYAO) website.
Chronic fatigue can negatively affect a person's health-related quality of life and ability to work and carry out normal daily functions. Authors Hanne Hamre, MD and colleagues Oslo University Hospital and University of Oslo Norway used a questionnaire, clinical examination, and blood samples to compare adult survivors of childhood leukemia and lymphoma to a control group from the general population. The prevalence of chronic fatigue was 27% among the cancer survivors compared to 8% among controls.
In the article "High Prevalence of Chronic Fatigue in Adult Long-Term Survivors of Acute Lymphoblastic Leukemia and Lymphoma during Childhood and Adolescence," (http://online.liebertpub.com/doi/full/10.1089/jayao.2012.0015) the authors describe factors predictive of chronic fatigue among the adult cancer survivors and present blood analysis findings suggestive of a persistent low-grade inflammatory response that may contribute to the chronic fatigue.
"Chronic fatigue in cancer survivors is often an under-appreciated complication of treatment," says Editor-in-Chief Leonard S. Sender, MD, of the University of California, Irvine and CHOC Children's Hospital. "There is a general belief that after successful treatment a survivor should be able to bounce back without lasting effects. Hamre and colleagues demonstrate that fatigue is a larger problem than generally appreciated. Their findings put a spotlight on this key aspect of cancer survivorship and serve to encourage the medical community to communicate with cancer survivor patients about possible chronic fatigue."
INFORMATION:
About the Journal
Journal of Adolescent and Young Adult Oncology (JAYAO) (http://www.liebertpub.com/JAYAO) is a quarterly peer-reviewed journal, published online with Open Access options (http://www.liebertpub.com/openaccess/jayao) and in print, dedicated to the promotion of interdisciplinary research, education, communication, and collaboration between health professionals in AYA oncology. JAYAO provides a forum for AYA cancer research and practice advances for all professional participants and researchers in care for AYA-aged cancer patients and survivors. Our multidisciplinary editorial board and readership includes but is not limited to: pediatric, medical, and surgical oncologists of all types and specialties; oncology nurses and advanced practice staff; psychosocial and supportive care providers including psychiatrists, psychologists, and social workers; translational cancer researchers; and academic- and community-based pediatric and adult cancer institutions. Complete tables of content and a sample issue (http://online.liebertpub.com/toc/jayao/1/1) are available on the Journal of Adolescent and Young Adult Oncology (JAYAO) (http://www.liebertpub.com/JAYAO) website.
About the Society
The Society for Adolescent and Young Adult Oncology (SAYAO) (http://www.sayao.org) is an international professional organization dedicated to improving adolescent and young adult cancer care through the promotion of interdisciplinary research, education, communication, and collaboration among health professionals. Patients and survivors aged 15-39 are a distinct patient population within oncology, and SAYAO focuses on the unique biological, clinical, psychosocial, and survivorship issues of this age group.
About the Publisher
Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com) is a privately held, fully integrated media company known for establishing authoritative medical and biomedical peer-reviewed journals, including Journal of Palliative Medicine and Cancer Biotherapy and Radiopharmaceutials. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's over 70 journals, newsmagazines, and books is available on the Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com) website.
Are survivors of childhood leukemia and lymphoma at greater risk of chronic fatigue as adults?
2013-03-20
ELSE PRESS RELEASES FROM THIS DATE:
Biennial mammograms best after 50, even for women with dense breasts
2013-03-20
Screening for breast cancer every two years appears just as beneficial as yearly mammograms for women ages 50 to 74, with significantly fewer "false positives" – even for women whose breasts are dense or who use hormone therapy for menopause.
That is the finding of a new national study involving more than 900,000 women.
The study was published on March 18 in JAMA Internal Medicine.
The same team of researchers from UC San Francisco and Seattle-based Group Health Research Institute recently reported similar results for older women ages 66 to 89 years old.
By contrast, ...
Record simulations conducted on Lawrence Livermore supercomputer
2013-03-20
LIVERMORE, Calif. -- Researchers at Lawrence Livermore National Laboratory have performed record simulations using all 1,572,864 cores of Sequoia, the largest supercomputer in the world. Sequoia, based on IBM BlueGene/Q architecture, is the first machine to exceed one million computational cores. It also is No. 2 on the list of the world's fastest supercomputers, operating at 16.3 petaflops (16.3 quadrillion floating point operations per second).
The simulations are the largest particle-in-cell (PIC) code simulations by number of cores ever performed. PIC simulations ...
To make health systems more effective, physicians say time is now for clinician-led innovation
2013-03-20
(Boston) –Physician experts in health system issues propose a timely alternative process for harnessing and supporting physician-led innovations to rapidly address front-line health care delivery problems and improve health. Published as a Viewpoint article in the March 20th issue of the Journal of the American Medical Association (JAMA), the authors propose health systems adopt a strategy widely accepted in U.S. industries of "user-led" innovation.
User-led innovation is predicated on the idea that important enhancements to products and services are often made by users ...
University of Maryland researchers identify fish protein that may inhibit cancer metastasis
2013-03-20
BALTIMORE – March 19, 2013. Researchers at the University of Maryland School of Medicine have identified a peptide, or protein, derived from Pacific cod that may inhibit prostate cancer and possibly other cancers from spreading, according to preclinical research published online in the Proceedings of the National Academy of Sciences (PNAS).
"The use of natural dietary products with anti-tumor activity is an important and emerging field of research," says senior author Hafiz Ahmed, Ph.D., assistant professor of biochemistry and molecular biology at the University of Maryland ...
Transportation study reveals potential for deep cuts to petroleum use and carbon emissions
2013-03-20
The U.S. Department of Energy's (DOE) National Renewable Energy Laboratory (NREL) and Argonne National Laboratory (ANL) today announced the release of the Transportation Energy Futures (TEF) study, an assessment of avenues to reach deep cuts in petroleum use and greenhouse gas (GHG) emissions in the transportation sector.
"Transportation is an engine of our economic strength, but it also represents a key challenge for the future of U.S. energy use," NREL Senior Analyst Austin Brown said. "Transportation accounts for 71 percent of total U.S. petroleum consumption and 33 ...
Highlights from the March GIE: Gastrointestinal Endoscopy special issue on colorectal cancer
2013-03-20
OAK BROOK, Ill. – March 19, 2013 – In recognition of National Colorectal Cancer Awareness Month, GIE: Gastrointestinal Endoscopy has published a special issue for March on colorectal cancer. The issue includes a practical guide for approaching and managing serrated colon polyps, one of the most common types of polyps, and a study on reducing postpolypectomy bleeding with prophylactic clip closure. GIE: Gastrointestinal Endoscopy is the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE).
"The cutting edge of serrated ...
Nurses can play key role in reducing deaths from world's most common diseases
2013-03-20
Nurses and midwives can play a critical role in lessening people's risk of cardiovascular diseases, cancers, chronic respiratory disease and diabetes, according to a groundbreaking new report issued by the World Health Organization and co-authored by a UCLA nursing professor.
These four non-communicable disease types account for a combined 60 percent of all deaths worldwide.
"The global burden of non-communicable diseases is already high and continues to grow in all regions of the world," said Linda Sarna, a professor at the UCLA School of Nursing and co-author ...
US company identified as manufacture of lead paint in Africa
2013-03-20
SAN FRANCISCO, CA (March 19, 2013) - House paint containing dangerous
concentrations of lead is being sold in Cameroon by an American company – and the
company is refusing to remove the paint from store shelves.
"There is an immediate need for regulations to restrict the lead content of paint in
Cameroon to protect public health," said Perry Gottesfeld, Executive Director of
Occupational Knowledge International (OK International) and co-author of a new
research study about this lead hazard.
"The levels of lead are extraordinarily high, and these products have been ...
Study could aid development of new drugs to treat gout
2013-03-20
MAYWOOD, Ill. – Findings from a Loyola University Chicago Stritch School of Medicine study could lead to the development of new drugs to treat gout.
The study, led by Liang Qiao, MD, and his colleagues and collaborators, was published March 19 in the journal Nature Communications.
Gout is caused by a buildup of uric acid around joints, typically the big toe, knee or ankles. The immune system revs up to attack uric acid salt crystals, and this immune response causes painful inflammation.
The innate immune response is mainly activated by calcium that enters a macrophage ...
Mayo Clinic researchers develop test to gauge severity of concussions
2013-03-20
SAN DIEGO — Neurologists at Mayo Clinic in Arizona have taken a promising step toward identifying a test that helps support the diagnosis of concussion. Their research has shown that autonomic reflex testing, which measures involuntary changes in heart rate and blood pressure, consistently appear to demonstrate significant changes in those with concussion. They presented the findings at the American Academy of Neurology annual meeting in San Diego this week.
Right now doctors rely primarily on self-reporting of symptoms to make a diagnosis of concussion. In addition, ...